Skip to main content
NCBI home page
CMAJ : Canadian Medical Association Journal logoLink to CMAJ : Canadian Medical Association Journal
. 1988 May 15;138(10):899–902.

The use of infants in drug research when there is no direct benefit to them: a survey of Canadian health care professionals serving on ethics committees.

G Koren 1, J Litwack 1, D W Biggar 1
PMCID: PMC1267844  PMID: 3365625

Abstract

Canadian health care professionals and lawyers serving on ethics committees were questioned about their views on pharmacokinetic research in newborn infants who are not likely to benefit directly from the results. Of the 50 respondents 13 felt that blood samples should be taken only for therapeutic reasons; 10 of the 13 argued that additional blood samples should not be taken, because there is no direct benefit to the infant; and 8 felt that proxy consent cannot be given for invasive nontherapeutic research. Four of the five participating lawyers would not permit additional blood samples to be taken. Of the 37 respondents who would permit additional blood samples to be taken, 27 felt that the number of samples taken should depend on the researcher's justification for that number of samples; only 7 of the respondents had a clear idea of what the "upper limit" of the number of blood samples should be.

Full text

PDF
899

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aranda J. V., Collinge J. M., Clarkson S. Epidemiologic aspects of drug utilization in a newborn intensive care unit. Semin Perinatol. 1982 Apr;6(2):148–154. [PubMed] [Google Scholar]
  2. Dworkin G. Legality of consent to nontherapeutic medical research on infants and young children. Arch Dis Child. 1978 Jun;53(6):443–446. doi: 10.1136/adc.53.6.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Feinstein A. R. Clinical biostatistics. XXVI. Medical ethics and the architecture of clinical research. Clin Pharmacol Ther. 1974 Mar;15(3):316–334. doi: 10.1002/cpt1974153316. [DOI] [PubMed] [Google Scholar]
  4. Meissner H. C., Smith A. L. The current status of chloramphenicol. Pediatrics. 1979 Sep;64(3):348–356. [PubMed] [Google Scholar]
  5. Pratt H. Research on infants. Lancet. 1977 Mar 26;1(8013):699–699. doi: 10.1016/s0140-6736(77)92134-1. [DOI] [PubMed] [Google Scholar]
  6. Pratt H. Research on infants. Lancet. 1977 May 14;1(8020):1052–1052. doi: 10.1016/s0140-6736(77)91278-8. [DOI] [PubMed] [Google Scholar]
  7. Shirkey H. Therapeutic orphans. J Pediatr. 1968 Jan;72(1):119–120. doi: 10.1016/s0022-3476(68)80414-7. [DOI] [PubMed] [Google Scholar]

Articles from CMAJ: Canadian Medical Association Journal are provided here courtesy of Canadian Medical Association

RESOURCES